Abstract
Encouraging selectivity and low micromolar activity against HeLa cervical carcinoma (IC50⩾3.0μM) and the aggressive MDA-MB-231 triple negative breast carcinoma (IC50⩾9.6μM) cell lines has been exhibited by a number of readily accessible 4-(N-benzylamino)cinnamate esters. The potential of the ligands as HIV-1 integrase inhibitors has also been examined.
Keywords:
4-(N-Benzylamino)cinnamate esters; Anti-cancer agents; HIV-1 integrase inhibitors.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Cinnamates / chemical synthesis
-
Cinnamates / chemistry
-
Cinnamates / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Esters / chemical synthesis
-
Esters / chemistry
-
Esters / pharmacology*
-
HEK293 Cells
-
HIV Integrase / metabolism*
-
HIV Integrase Inhibitors / chemical synthesis
-
HIV Integrase Inhibitors / chemistry
-
HIV Integrase Inhibitors / pharmacology*
-
HeLa Cells
-
Humans
-
Molecular Structure
-
Structure-Activity Relationship
Substances
-
Antineoplastic Agents
-
Cinnamates
-
Esters
-
HIV Integrase Inhibitors
-
HIV Integrase